Gilead Sciences, Inc. - Strategy, SWOT and Corporate Finance Report
Summary
Gilead Sciences, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
Gilead Sciences, Inc. (Gilead or 'the company') is a biopharmaceutical company. The company develops and markets medicines for HIV/AIDS, liver diseases, oncology, inflammation and serious cardiovascular and respiratory conditions. The company offers its products under several brand names, including AmBisome, Atripla, Cayston, Complera/Eviplera, Emtriva, Genvoya, Hepsera, Harvoni, Letairis, Lexiscan /Rapiscan, Macugen, Ranexa, Stribild, Tamiflu, Truvada, Tybost, Viread, Vosevi, Zydelig and Sovaldi. Gilead markets its products through commercial teams and in conjunction with third-party distributors and corporate partners. The company sells and distributes most of its products in the US through the wholesale channel. It has business presence in the US, Europe, and other countries. The company is headquartered in Foster City, California, the US.
Scope
- Detailed information on Gilead Sciences, Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Gilead Sciences, Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Gilead Sciences, Inc. including a breakdown and examination of key business segments
- Intelligence on Gilead Sciences, Inc.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Gilead Sciences, Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
- Gain understanding of Gilead Sciences, Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Gilead Sciences, Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers' businesses better.
- Stay up to date on Gilead Sciences, Inc.'s business structure, strategy and prospects.
- Company Snapshot
- GNC Holdings, Inc.: Company Overview
- GNC Holdings, Inc.: Overview and Key Facts
- GNC Holdings, Inc.: Overview
- GNC Holdings, Inc.: Key Facts
- GNC Holdings, Inc.: Key Employees
- GNC Holdings, Inc.: Key Employee Biographies
- GNC Holdings, Inc.: Major Products and Services
- GNC Holdings, Inc.: Key Competitors
- GNC Holdings, Inc.: Company Analysis
- GNC Holdings, Inc.: Business Description
- GNC Holdings, Inc.: SWOT Analysis
- GNC Holdings, Inc.: SWOT Overview
- GNC Holdings, Inc.: Strengths
- GNC Holdings, Inc.: Weaknesses
- GNC Holdings, Inc.: Opportunities
- GNC Holdings, Inc.: Threats
- GNC Holdings, Inc.: Corporate Financial Deals Activity
- GNC Holdings, Inc.: Financial Deals Overview
- GNC Holdings, Inc.: Top Deals 2019 - 2023YTD*
- GNC Holdings, Inc.: Advisors
- GNC Holdings, Inc.: Top Legal Advisors
- GNC Holdings, Inc.: Top Financial Advisors
- GNC Holdings, Inc.: Corporate Venturing
- GNC Holdings, Inc.: Partnership
- GNC Holdings, Inc.: Private Equity and Ownership
- GNC Holdings, Inc.: Recent Developments
- GNC Holdings, Inc.: News and Events Summary
- GNC Holdings, Inc.: Business Expansion
- GNC Holdings, Inc.: Contracts
- GNC Holdings, Inc.: Corporate Governance
- GNC Holdings, Inc.: Financial Deals
- GNC Holdings, Inc.: Strategy and Operations
- Appendix
- Contact Us
- Methodology
- About MarketLine
- List of Tables
- Table 1: GNC Holdings, Inc.: Key Facts
- Table 2: GNC Holdings, Inc.: Key Employees
- Table 3: GNC Holdings, Inc.: Key Competitors
- Table 4: GNC Holdings, Inc.: Deal Activity by Deal Type - Volume (2019 - YTD*2023)
- Table 5: GNC Holdings, Inc.: Top Deals 2019 - 2023YTD*
- Table 6: GNC Holdings, Inc.: Legal Advisor Ranking by Value (US$m)
- Table 7: GNC Holdings, Inc.: Financial Advisor Ranking by Value (US$m)
- Table 8: GNC Holdings, Inc.: Corporate Venturing Volume and Value Trend (2019 - YTD*2023)
- Table 9: GNC Holdings, Inc.: Partnership Volume and Value Trend (2019 - YTD*2023)
- Table 10: GNC Holdings, Inc.: Partnership Trend by Deal Type (2019 - YTD*2023)
- Table 11: GNC Holdings, Inc.: Private Equity and Ownership Volume and Value Trend (2019 - YTD*2023)
- Table 12: GNC Holdings, Inc.: Private Equity and Ownership Volume by Deal Type (2019 - YTD*2023)
- Table 13: GNC Holdings, Inc.: News and Events Summary
- Table 14: GNC Holdings, Inc.: Business Expansion
- Table 15: GNC Holdings, Inc.: Contracts
- Table 16: GNC Holdings, Inc.: Corporate Governance
- Table 17: GNC Holdings, Inc.: Financial Deals
- Table 18: GNC Holdings, Inc.: Strategy and Operations
- List of Figures
- Figure 1: GNC Holdings, Inc.: Deal Activity by Deal Type - Volume (2019 - YTD*2023)
- Figure 2: GNC Holdings, Inc.: Corporate Venturing Volume and Value Trend (2019 - YTD*2023)
- Figure 3: GNC Holdings, Inc.: Partnership Volume and Value Trend (2019 - YTD*2023)
- Figure 4: GNC Holdings, Inc.: Partnership Trend by Deal Type (2019 - YTD*2023)
- Figure 5: GNC Holdings, Inc.: Private Equity and Ownership Volume and Value Trend (2019 - YTD*2023)
- Figure 6: GNC Holdings, Inc.: Private Equity and Ownership Volume by Deal Type (2019 - YTD*2023)
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook